Coastal Bridge Advisors, LLC Halozyme Therapeutics, Inc. Transaction History

Coastal Bridge Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$33.68 - $41.95 $67,360 - $83,900	2,000 Added 25.0%	10,000 $406,000
Q4 2023 Feb 15, 2024	BUY	$33.32 - $42.1 $66,640 - $84,200	2,000 Added 33.33%	8,000 $295,000
Q2 2023 Aug 16, 2023	BUY	$30.28 - $38.74 $181,680 - $232,440	6,000 New	6,000 $216,000
Q2 2018 Aug 03, 2018	SELL	$16.87 - $20.3 $1.01 Million - $1.22 Million	-60,153 Closed	0 $0
Q3 2017 Nov 13, 2017	SELL	$11.76 - $17.4 $1.13 Million - $1.67 Million	-95,804 Reduced 61.43%	60,153 $1.05 Million
Q1 2017 Aug 14, 2017	BUY	N/A	155,957	155,957 $2.02 Million

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.57B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Coastal Bridge Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Coastal Bridge Advisors, LLC with notifications on news.